Ayman Megally

13 papers receiving 466 citations

Ayman Megally's Hit Papers

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps 2025 · 51 citations
510+1+3Years since publication50100150200

Peers

Ayman Megally
Comparison fields: 5 of 39
  • Immunology and Allergy 124
  • Otorhinolaryngology 61
  • Physiology 326
  • Dermatology 47
  • Immunology 95
Replace Jean‐Pierre Llanos with:
Jean‐Pierre Llanos United States
О М Курбачева Russia
Evangelia Fouka Greece
S. Pollard United States
Marcello Cottini Italy
Carlo Mümmler Germany
Laurence Gozalo United States
G. Fischer Austria
Michaela Barnikel Germany
P. Rufin France
Ayman Megally relative to Jean‐Pierre Llanos United States Jean‐Pierre Llanos's profile →
Citations per field
00.5×1.7×
Jean‐Pierre Llanos · 1×
Citations per year

Countries citing papers authored by Ayman Megally

Since Specialization
Citations

This map shows the geographic impact of Ayman Megally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Megally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Megally more than expected).

Fields of papers citing papers by Ayman Megally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Megally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Megally. The network helps show where Ayman Megally may publish in the future.

Co-authors

The 25 scholars most cited alongside Ayman Megally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ayman Megally Line = papers co-authored together Ayman Megally links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
2021238
2 202363
3
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
Hit paper breakdown →
202551
4 202335
5 202027
6 202022
7 202119
8 201913
9 20242
10 20241
11 20231
12 20251
13 20211
14 20260
15 20240

About Ayman Megally

Ayman Megally is a scholar working on Physiology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Immunology and Allergy and Immunology, having authored 15 papers that have together received 474 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), Sinusitis and nasal conditions (3 papers), Allergic Rhinitis and Sensitization (2 papers), Respiratory and Cough-Related Research (2 papers), Inhalation and Respiratory Drug Delivery (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper). The work is most often cited by research in Immunology and Allergy (124 citations), Otorhinolaryngology (61 citations), Physiology (326 citations), Dermatology (47 citations) and Immunology (95 citations). Ayman Megally has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Gene Colice, Christopher E. Brightling, Sarah Diver, Jane R. Parnes, Claire Emson, Andrew Menzies‐Gow, Sally E. Wenzel, Michael E. Wechsler, Latifa Khalfaoui and Néstor A. Molfino. Their work appears in journals such as The Lancet Respiratory Medicine, Respiratory Research, Journal of Asthma and Allergy, International Journal of COPD and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact